Developer docs
API playgroundTry for free, no card

Search company profiles

CyMedica

Full company profile

uuid00034gw

Namestring
CyMedica
Legal namestring
Motive Health, Inc.
Company typeenum
Private
Founded yearint
2013
Descriptiontext

CyMedica Orthopedics, now operating as Motive Health, Inc., is a privately held medical device company headquartered in Scottsdale, Arizona that develops and commercializes the e-vive, a clinically proven at-home muscle strengthening therapy device targeting knee pain and joint-related muscle atrophy. The company sells the device directly to individual consumers via its MyMotive e-commerce platform (mymotive.com) without requiring a prescription, distinguishing it from traditional prescription-based orthopedic medical device distribution channels. CyMedica was founded in 2013 and rebranded to Motive Health in 2023 to align with its consumer-facing positioning; the company is incorporated in Delaware and has filed SEC Form D exempt securities offerings under both the legacy CyMedica and Motive Health entities in 2023.

The company's underlying technology is a proprietary neuromuscular electrical stimulation (NMES) device designed to deliver muscle strengthening therapy in a home setting, replacing or supplementing clinical physical therapy regimens. Its go-to-market motion is exclusively direct-to-consumer: customers purchase the device directly from mymotive.com, with lead generation handled via the corporate website (cymedicaortho.com) and email signup workflows. Revenue is generated primarily through one-time hardware sales, with no disclosed subscription, recurring, or services component in available sources. The company maintains a small team (11-50 employees) and does not disclose named enterprise customers, partnerships, patents, or third-party distribution relationships, indicating a concentrated, vertically integrated DTC operating model.

Short descriptiontext

CyMedica (now Motive Health) develops and sells the e-vive, an at-home muscle strengthening therapy device for knee pain relief, distributed directly to individual consumers via its MyMotive e-commerce platform without prescription.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersTempe, United States
HQ citystring
Tempe
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
muscle strengthening therapy, knee pain relief, orthopedic medical device, at-home rehabilitation, electrical muscle stimulation
Industry3 codes
1Pain Management (Spine & Musculoskeletal)
CodeHLAKALAMPrimaryYes
2Orthotics & Bracing (AFO/KAFO, Spinal, Soft Goods Supports)
CodeHLAHAMACPrimaryNo
3General Orthopedics
CodeHLAKALAAPrimaryNo
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Consumer Orthopedic Medical Devices
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device Sales
TypeHardware Sales
Description

CyMedica generates revenue through direct sales of their e-vive muscle strengthening therapy device to consumers seeking at-home treatment for knee pain. The device is available for purchase directly online without a prescription.

cymedicaortho.com:443
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Operations, Infrastructure
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1e-vive
Description

Clinically proven at-home muscle strengthening therapy for lasting knee pain relief

cymedicaortho.com:443
Core offering1 text field

CyMedica Orthopedics (operating as Motive Health, Inc.) develops and sells the e-vive, an at-home electrical muscle strengthening therapy device designed for lasting knee pain relief. The device is sold directly to consumers online without requiring a prescription through the mymotive.com platform. The company is a single-product orthopedic medical device firm repositioning its offering for the consumer market under the Motive Health brand.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Clinically proven muscle strengthening therapy for lasting knee pain relief
Product overview1 text field

CyMedica Orthopedics, now operating as Motive Health, Inc., offers a single unified product: the e-vive muscle strengthening therapy system. This at-home therapy device is designed for lasting knee pain relief and is available directly to consumers online without a prescription. The company transitioned its brand from CyMedica to Motive Health, consolidating its consumer-facing offering under the Motive brand.

Product and service1 record
1e-vive Muscle Strengthening Therapy Device
CategoryOrthopedic medical device / consumer muscle stimulation therapy
Description

An at-home electrical muscle strengthening therapy device that delivers clinically proven muscle strengthening treatment for lasting knee pain relief. Sold directly to individual consumers via mymotive.com without requiring a prescription or clinical visit.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Public company that markets consumer-facing neurostimulation devices (e.g., Quell) for chronic pain relief via direct-to-consumer and online channels. Highly comparable to CyMedica/Motive Health in product modality (electrotherapy for pain), DTC motion, and indication overlap.

TypeDirect peer
Description

Sells TENS/EMS and other electrotherapy devices for pain management and rehabilitation, including consumer and prescription channels. Comparable to CyMedica in device category and musculoskeletal pain positioning.

TypeBroad incumbent
Description

Large orthopedic and rehabilitation device manufacturer (DonJoy, Chattanooga, Compex) that sells electrical stimulation, bracing, and rehab products. Comparable to CyMedica as the dominant incumbent in musculoskeletal rehab hardware, though distribution-led rather than DTC.

TypeDirect peer
Description

Direct-to-consumer EMS/muscle stimulation brand owned by Enovis, selling muscle strengthening and recovery devices to consumers and athletes. Closest large-brand analog to the e-vive product and go-to-market approach.

TypeBroad incumbent
Description

Global consumer medical device company that sells TENS/EMS units (e.g., Avail, PocketTens) for pain relief through retail and online. Comparable as a broad incumbent in consumer electrotherapy for pain.

TypeEmerging player
Description

Consumer recovery and muscle activation brand (Theragun, RecoveryAir, RecoveryPulse EMS) that competes for the same at-home muscle/pain consumer wallet. Comparable as a direct-to-consumer adjacent player in muscle recovery hardware.

TypeEmerging player
Description

Digital musculoskeletal platform bundling virtual PT, coaching, and increasingly in-home hardware (e.g., Enso) for employers and payers. Comparable as an emerging alternative delivery model that addresses the same knee/musculoskeletal pain patients CyMedica targets, but via subscription software rather than hardware.

TypeEmerging player
Description

Digital MSK platform offering AI-guided virtual physical therapy and remote monitoring for employers and health plans. Comparable to CyMedica as an emerging competitor targeting the same knee/back pain population with a recurring-revenue model.

TypeOthers
Description

European consumer health and wellness brand with a broad TENS/EMS portfolio sold through retail and online. Comparable as an adjacent consumer electrotherapy competitor in the same product category.

TypeOthers
Description

Consumer wearable that uses low-frequency stimulation for stress, sleep, and recovery. Comparable as a thematic adjacent player using wearable electrostimulation for at-home wellness/pain-adjacent use cases.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CyMedica

Consumer Orthopedic Medical Devicescymedicaortho.com

CyMedica (now Motive Health) develops and sells the e-vive, an at-home muscle strengthening therapy device for knee pain relief, distributed directly to individual consumers via its MyMotive e-commerce platform without prescription.

What CyMedica does

CyMedica Orthopedics, now operating as Motive Health, Inc., is a privately held medical device company headquartered in Scottsdale, Arizona that develops and commercializes the e-vive, a clinically proven at-home muscle strengthening therapy device targeting knee pain and joint-related muscle atrophy. The company sells the device directly to individual consumers via its MyMotive e-commerce platform (mymotive.com) without requiring a prescription, distinguishing it from traditional prescription-based orthopedic medical device distribution channels. CyMedica was founded in 2013 and rebranded to Motive Health in 2023 to align with its consumer-facing positioning; the company is incorporated in Delaware and has filed SEC Form D exempt securities offerings under both the legacy CyMedica and Motive Health entities in 2023.

The company's underlying technology is a proprietary neuromuscular electrical stimulation (NMES) device designed to deliver muscle strengthening therapy in a home setting, replacing or supplementing clinical physical therapy regimens. Its go-to-market motion is exclusively direct-to-consumer: customers purchase the device directly from mymotive.com, with lead generation handled via the corporate website (cymedicaortho.com) and email signup workflows. Revenue is generated primarily through one-time hardware sales, with no disclosed subscription, recurring, or services component in available sources. The company maintains a small team (11-50 employees) and does not disclose named enterprise customers, partnerships, patents, or third-party distribution relationships, indicating a concentrated, vertically integrated DTC operating model.

CyMedica firmographics

Firmographics
Name
CyMedica
Legal name
Motive Health, Inc.
Website
https://cymedicaortho.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
11–50 employees
Short description
CyMedica (now Motive Health) develops and sells the e-vive, an at-home muscle strengthening therapy device for knee pain relief, distributed directly to individual consumers via its MyMotive e-commerce platform without prescription.
Ownership category
akta.pro rank

CyMedica industry classification

Industry
Product category
Consumer Orthopedic Medical Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro primary industry
Pain Management (Spine & Musculoskeletal) (HLAKALAM)
akta.pro secondary industries
Orthotics & Bracing (AFO/KAFO, Spinal, Soft Goods Supports) (HLAHAMAC), General Orthopedics (HLAKALAA)

Keywords

  • Muscle strengthening therapy
  • Knee pain relief
  • Orthopedic medical device
  • At-home rehabilitation
  • Electrical muscle stimulation

Where CyMedica is headquartered

Location

Headquarters

HQ city
Tempe
HQ country
United States
HQ region
North America

Offices1 record

Markets served

CyMedica business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Operations, Infrastructure

Revenue model

  1. Medical Device Sales: CyMedica generates revenue through direct sales of their e-vive muscle strengthening therapy device to consumers seeking at-home treatment for knee pain. The device is available for purchase directly online without a prescription.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

CyMedica product offering

Product offering

Core offering

CyMedica Orthopedics (operating as Motive Health, Inc.) develops and sells the e-vive, an at-home electrical muscle strengthening therapy device designed for lasting knee pain relief. The device is sold directly to consumers online without requiring a prescription through the mymotive.com platform. The company is a single-product orthopedic medical device firm repositioning its offering for the consumer market under the Motive Health brand.

Product overview

CyMedica Orthopedics, now operating as Motive Health, Inc., offers a single unified product: the e-vive muscle strengthening therapy system. This at-home therapy device is designed for lasting knee pain relief and is available directly to consumers online without a prescription. The company transitioned its brand from CyMedica to Motive Health, consolidating its consumer-facing offering under the Motive brand.

Differentiator

Problem solved

Functional benefit

Brands

  • e-vive: Clinically proven at-home muscle strengthening therapy for lasting knee pain relief

Products and services

  • e-vive Muscle Strengthening Therapy Device An at-home electrical muscle strengthening therapy device that delivers clinically proven muscle strengthening treatment for lasting knee pain relief. Sold directly to individual consumers via mymotive.com without requiring a prescription or clinical visit.

Quantifiable outcome

  • Clinically proven muscle strengthening therapy for lasting knee pain relief

Companies that use CyMedica

Customer profile

Segments1 record

Ideal customer profiles1 record

CyMedica technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

CyMedica partnerships and signals

Strategic signal

Scale indicators2 records

Expansion highlights4 records

CyMedica competitors and assessment

Company assessment

Direct peers

  • NeuroMetrix: Public company that markets consumer-facing neurostimulation devices (e.g., Quell) for chronic pain relief via direct-to-consumer and online channels. Highly comparable to CyMedica/Motive Health in product modality (electrotherapy for pain), DTC motion, and indication overlap.
  • Zynex Medical: Sells TENS/EMS and other electrotherapy devices for pain management and rehabilitation, including consumer and prescription channels. Comparable to CyMedica in device category and musculoskeletal pain positioning.
  • Compex (within Enovis/DJO): Direct-to-consumer EMS/muscle stimulation brand owned by Enovis, selling muscle strengthening and recovery devices to consumers and athletes. Closest large-brand analog to the e-vive product and go-to-market approach.

Broad incumbents

  • DJO (Enovis): Large orthopedic and rehabilitation device manufacturer (DonJoy, Chattanooga, Compex) that sells electrical stimulation, bracing, and rehab products. Comparable to CyMedica as the dominant incumbent in musculoskeletal rehab hardware, though distribution-led rather than DTC.
  • Omron Healthcare: Global consumer medical device company that sells TENS/EMS units (e.g., Avail, PocketTens) for pain relief through retail and online. Comparable as a broad incumbent in consumer electrotherapy for pain.

Emerging players

  • Therabody: Consumer recovery and muscle activation brand (Theragun, RecoveryAir, RecoveryPulse EMS) that competes for the same at-home muscle/pain consumer wallet. Comparable as a direct-to-consumer adjacent player in muscle recovery hardware.
  • Hinge Health: Digital musculoskeletal platform bundling virtual PT, coaching, and increasingly in-home hardware (e.g., Enso) for employers and payers. Comparable as an emerging alternative delivery model that addresses the same knee/musculoskeletal pain patients CyMedica targets, but via subscription software rather than hardware.
  • Sword Health: Digital MSK platform offering AI-guided virtual physical therapy and remote monitoring for employers and health plans. Comparable to CyMedica as an emerging competitor targeting the same knee/back pain population with a recurring-revenue model.

Others

  • Beurer: European consumer health and wellness brand with a broad TENS/EMS portfolio sold through retail and online. Comparable as an adjacent consumer electrotherapy competitor in the same product category.
  • Apollo Neuroscience: Consumer wearable that uses low-frequency stimulation for stress, sleep, and recovery. Comparable as a thematic adjacent player using wearable electrostimulation for at-home wellness/pain-adjacent use cases.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

CyMedica social profiles

Digital presence

CyMedica financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CyMedica leadership team

Management profile

Number of profiles

Profiles6 records

CyMedica funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CyMedica M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CyMedica

What does CyMedica do?

CyMedica Orthopedics (operating as Motive Health, Inc.) develops and sells the e-vive, an at-home electrical muscle strengthening therapy device designed for lasting knee pain relief. The device is sold directly to consumers online without requiring a prescription through the mymotive.com platform. The company is a single-product orthopedic medical device firm repositioning its offering for the consumer market under the Motive Health brand.

Is CyMedica a public or private company?

CyMedica is a private company. It is classified as venture growth investor backed and is currently operating.

When was CyMedica founded?

CyMedica was founded in 2013. It employs 11 to 50 people.

Where is CyMedica based?

CyMedica is headquartered in Tempe, United States, in the North America region.

How does CyMedica make money?

One revenue line is on record: medical Device Sales.

Who are CyMedica's main competitors?

Direct peers on record are NeuroMetrix, Zynex Medical and Compex (within Enovis/DJO). Broad incumbents are DJO (Enovis) and Omron Healthcare. Emerging players are Therabody, Hinge Health and Sword Health. Others are Beurer and Apollo Neuroscience.

Does CyMedica have an API?

No public API is recorded for CyMedica.

What industry is CyMedica in?

CyMedica's product category is Consumer Orthopedic Medical Devices. Its primary akta.pro industry code is HLAKALAM, Pain Management (Spine & Musculoskeletal), with a secondary code of HLAHAMAC, Orthotics & Bracing (AFO/KAFO, Spinal, Soft Goods Supports). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
SecSEC FORM DCyMedica Orthopedics, Inc. filed a Form D with the Securities and Exchange Commission to report an exempt securities offering under Rule 506(b). The company disclosed a total offering amount of $6 million, with approximately $2.58 million sold as of January 17, 2023, to three investors.PR NewswireCyMedica Orthopedics Completes e-vive Parent Clinical Trial for Management of Knee Osteoarthritis PainCyMedica Orthopedics announced the completion of early enrollment of 159 patients in its FDA-regulated clinical trial for the e-vive technology, a home-based muscle strengthening therapy for knee osteoarthritis pain, prior to the COVID-19 pandemic. Due to the remote monitoring capabilities of the device, trial participants were able to continue treatment at home during pandemic-related restrictions, prompting activation of a rollover study extending treatment by an additional 14 weeks to bolster results. The parent trial data collection was completed in May 2020, and findings from this randomized, controlled study will support CyMedica's future indications and reimbursement opportunities for the CyMotion portfolio.PR NewswireCyMedica Launches e-vive™ Clinical Trial for Knee Osteoarthritis Utilizing Smartwatch TechnologyCyMedica Orthopedics has launched a randomized clinical trial with Northwell Health to evaluate the effectiveness of its FDA-cleared e-vive muscle strengthening device combined with commercially available smartwatch technology in 120 knee osteoarthritis patients. The prospective study will analyze activity and health data from wearable devices alongside e-vive patient engagement data to measure improvements in osteoarthritis symptoms. The company aims to address the growing need for non-opioid, home-based wearable therapies for the more than 14 million Americans suffering from symptomatic knee osteoarthritis, a condition costing over $24 billion annually.PR NewswireCyMedica Orthopedics® Announces Successful Clinical Trial Utilizing e-vive™CyMedica Orthopedics announced statistically significant positive results from a randomized controlled clinical trial evaluating its e-vive™ neuromuscular electrical stimulation system for patients undergoing total knee replacement. The trial of 66 patients demonstrated a 12.9% increase in quadriceps strength at 3 weeks post-operation compared to standard of care, which showed a 29% loss of quadriceps strength during the same period, along with improved Timed Up and Go test times at 6 and 12 weeks. The results, conducted by researchers at Cleveland Clinic, will be presented at the 2019 American Academy of Orthopedic Surgeons meeting.PR NewswireCyMedica Orthopedics® announces FDA clearance for e-vive™, the first app-driven muscle activation therapy and patient engagement solution for pre and post-operative knee surgery rehabilitationCyMedica Orthopedics announced receipt of FDA 510(k) clearance for e-vive, an app-controlled muscle activation therapy and patient engagement system designed for pre and post-operative rehabilitation of ACL and total knee replacement patients. The device addresses post-surgical muscle atrophy, where patients can lose over 60% of quad strength, a condition costing up to $4,200 per episode due to additional rehabilitation and higher readmission likelihood. The company is positioning the product to support value-based care by allowing remote patient monitoring through a cloud-based portal that tracks range of motion, activity levels, and pain scores.VC News DailyCyMedica Orthopedics Raises $11.5MCyMedica Orthopedics announced it closed an $11.5 million Series A financing extension, led by Research Corporation Technologies and California Technology Ventures with participation from Aphelion Capital. The funding will support expansion of the company's sales and distribution network and continued rollout of its CyMedica QB1 system, a medical device for treating quadriceps muscle atrophy using closed-loop electrical muscle stimulation technology.